Revolution Medicines Inc [NASDAQ: RVMD] loss -1.52% on the last trading session, reaching $1990000.0 price per share at the time.
Revolution Medicines Inc represents 186.26 million in outstanding shares, while the company has a total market value of $6.88 billion with the latest information. RVMD stock price has been found in the range of $36.77 to $37.995.
If compared to the average trading volume of 1.99M shares, RVMD reached a trading volume of 26224855 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Revolution Medicines Inc [RVMD]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RVMD shares is $72.91 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RVMD stock is a recommendation set at 1.08. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Needham have made an estimate for Revolution Medicines Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on July 16, 2024. While these analysts kept the previous recommendation, Barclays raised their target price to Overweight. The new note on the price target was released on July 12, 2024, representing the official price target for Revolution Medicines Inc stock. Previously, the target price had yet another raise to $63, while Jefferies analysts kept a Buy rating on RVMD stock. On April 12, 2024, analysts increased their price target for RVMD shares from 36 to 46.
The Price to Book ratio for the last quarter was 3.31, with the Price to Cash per share for the same quarter was set at 11.29.
Trading performance analysis for RVMD stock
Revolution Medicines Inc [RVMD] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -6.93. With this latest performance, RVMD shares dropped by -2.17% in over the last four-week period, additionally sinking by -15.98% over the last 6 months – not to mention a drop of -15.62% in the past year of trading.
Revolution Medicines Inc [RVMD]: A deeper dive into fundamental analysis
Return on Equity for this stock declined to -32.64%, with Return on Assets sitting at -32.64%.
Revolution Medicines Inc [RVMD]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for RVMD. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Revolution Medicines Inc go to -6.64%.
An analysis of Institutional ownership at Revolution Medicines Inc [RVMD]
There are presently around $105.97%, or 108.12% of RVMD stock, in the hands of institutional investors. The top three institutional holders of RVMD stocks are: VANGUARD GROUP INC with ownership of 14.38 million shares, which is approximately 8.7066%. WELLINGTON MANAGEMENT GROUP LLP, holding 13.66 million shares of the stock with an approximate value of $$530.15 million in RVMD stocks shares; and WELLINGTON MANAGEMENT GROUP LLP, currently with $$520.39 million in RVMD stock with ownership which is approximately 8.1195%.
